IHS’ debut at the 55th China Higher Education Expo

From November 8-10, Intelligent Haptronic Solutions (IHS) attended the 55th China Higher Education Expo, hosted by the China Higher Education Association and supported by the Hunan Provincial Education Department and Changsha Municipal People’s Government. The event, attended by over 1000 companies occupying more than 3000 exhibition booths, was held at the Changsha International Convention and Exhibition Center and featured the latest products in technology and higher education equipment, including artificial intelligence-enabled tools, cloud computing, 5G network support, and other products for improving education and practical training across multiple disciplines. In light of the COVID-19 pandemic, a major area of interest at the event was in the medical education and health domain, around infection prevention and control supplies for colleges and universities.

Leading innovation in medical education and hands-on surgical training

At the exhibition, IHS demoed our third generation virtual reality surgical simulator, receiving heavy attention from universities, academics, and distributors, and creating a forum for in-depth discussions with subject matter experts from various medical schools and medical device manufacturers. The advanced virtual reality, haptics, and artificial intelligence technology of our product drew attention to the need for technology-enabled solutions for accelerated medical training and enhanced educational standards. 

At present, IHS is in research and development with Beijing Tsinghua Changyu Hospital, Southern Medical University Shenzhen Hospital, Shenzhen University General Hospital and other large-scale, Tier 3 hospitals in China to guide product development and establish the basis for rigorous pilot testing and validation. 

IHS will begin mass production of our virtual reality endoscopy simulator at the end of December 2020 and conduct pilot testing at Shenzhen Hospital of Southern Medical University. We are currently seeking additional clinical and manufacturing parters in China, and pilot testers in North America.